Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus

Authors:

Abstract
No abstract available
Funding Information
  • Biomedical Laboratory Research and Development, VA Office of Research and Development
  • National Institutes of Health (K24-AR02207, R01AR071653)
  • U.S. Department of Veterans Affairs
  • Health Services Research and Development

This publication has 21 references indexed in Scilit: